WHO ICTRP trial
A randomized, double-blind, double dummy, placebo-controlled, four-way…
NL-OMON42337 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON42337 |
|---|---|
| Public title | A randomized, double-blind, double dummy, placebo-controlled, four-way, cross-over, single dose study to investigate the effects of paracetamol and THC on the PainCart in healthy subjects using promethazine as negative control |
| Scientific title | A randomized, double-blind, double dummy, placebo-controlled, four-way, cross-over, single dose study to investigate the effects of paracetamol and THC on the PainCart in healthy subjects using promethazine as negative control - PainCart validation: Paracetamol, THC and promethazine |
| Primary sponsor | Centre for Human Drug Research |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Pain Algesia pain;Algesia;pain |
| Interventions | During the course of the study, on every one of the study days, a subject will get, in random order: - Δ9-Tetrahydrocannabinol (Δ9-THC, Namisol®, ECP002A/5), provided by Echo Pharmaceuticals, \ (2 tablets of 5 mg will be administered) and… |
| Registration date | Sep 10, 2015 |
| Target size | 24 |
| Secondary IDs | 2015-003496-30;NL54643.056.15 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: